News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
BioSante Pharmaceuticals, Inc. Reports Product Development Highlights And Financial Results for 2005
March 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--March 31, 2006--BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced updated product development highlights, recent milestones and financial results for the year ended December 31, 2005.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Earnings
J&J Targets $50B Oncology Sales By 2030: Updated
July 16, 2025
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
July 16, 2025
·
1 min read
·
Tristan Manalac
Layoff Tracker
Ventus “Recalibrates” to Support Mid-Stage Trials
July 16, 2025
·
159 min read
·
BioSpace Editorial Staff
Podcast
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
July 16, 2025
·
1 min read
·
Heather McKenzie